Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Veracyte, Inc.
About VCYT
Veracyte, Inc. is a global diagnostics company. It enables clinicians with insights they need to guide and assure patients. The Company offers tests for thyroid cancer (Afirma), prostate cancer (Decipher Prostate), breast cancer (Prosigna), interstitial lung diseases (Envisia), and bladder cancer (Decipher Bladder). Its Percepta Nasal Swab test is being run in its Clinical Laboratory Improvement Amendments (CLIA) lab in support of clinical studies and its tests for kidney cancer and lymphoma are in development, the latter as a companion diagnostic. Its products consist of the Prosigna breast cancer assay, the nCounter Analysis System, related diagnostic kits, and services. In the United States, it offers laboratory developed tests (LDTs), through its CLIA laboratories in South San Francisco and San Diego, California, supported by its cytopathology know-how in Austin, Texas. The Company also offers whole-genome MRD platform that enable it in early cancer diagnosis and risk assessment.
Find out what a historical investment in Veracyte, Inc. would be worth today using our VCYT stock calculator.
Market Capitalisation
$3.33B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.18M
High today
$45.38
Low today
$41.86
Open price
$42.16
52-week high
$50.71
52-week low
$22.61
Ready to start your investing journey with Stake?
Open an accountHow do I buy VCYT shares in Australia?
Buying VCYT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Veracyte, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in VCYT
What is the ticker symbol of Veracyte, Inc.?
The ticker symbol for Veracyte, Inc. is VCYT.
How much is one share of VCYT?
One share of VCYT is valued at $45.31 as of 20 May 2026.
What is the market capitalisation of Veracyte, Inc. VCYT?
As of 20 May 2026 Veracyte, Inc. has a market cap of $3.33B.
What is the P/E ratio of VCYT?
The Price to Earnings ratio of VCYT is 38.61.
What is the Earnings Per Share of VCYT?
The Earnings Per Share of VCYT is $1.08.
What is the 52-week high for Veracyte, Inc. stock?
The Veracyte, Inc. 52-week high stock price is $50.71.
What is the 52-week low for Veracyte, Inc. stock?
The Veracyte, Inc. 52-week low stock price is $22.61.
Can I buy VCYT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy VCYT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in VCYT on Stake
- Buy VCYT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of VCYT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
VCYT related stocks